Total Payments
$2,883
2022 Payments
$46.70
Companies
19
Transactions
162
Medicare Patients
9,089
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$2,881 (99.9%)
Education$2.56 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,881 | 161 | 99.9% |
| Education | $2.56 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $878.37 | 44 | $0 (2021) |
| Daiichi Sankyo Inc. | $597.12 | 37 | $0 (2019) |
| BioDelivery Sciences International, Inc. | $339.35 | 19 | $0 (2021) |
| Allergan, Inc. | $222.13 | 20 | $0 (2020) |
| Lilly USA, LLC | $182.12 | 9 | $0 (2021) |
| Amgen Inc. | $137.86 | 2 | $0 (2019) |
| Arbor Pharmaceuticals, Inc. | $82.02 | 6 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $73.95 | 1 | $0 (2018) |
| Promius Pharma LLC | $70.65 | 5 | $0 (2018) |
| Fidia Pharma USA Inc. | $54.13 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $46.70 | 2 | Fidia Pharma USA Inc. ($24.94) |
| 2021 | $132.64 | 9 | Collegium Pharmaceutical, Inc. ($88.21) |
| 2020 | $350.43 | 23 | Collegium Pharmaceutical, Inc. ($113.90) |
| 2019 | $869.23 | 61 | BioDelivery Sciences International, Inc. ($173.20) |
| 2018 | $1,072 | 52 | Daiichi Sankyo Inc. ($403.02) |
| 2017 | $411.75 | 15 | Collegium Pharmaceutical, Inc. ($298.71) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/31/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2022 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: OSTEOARTHRITIS | ||||||
| 11/11/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.85 | General |
| Category: Opioid Analgesic | ||||||
| 10/19/2021 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Opioid Analgesic | ||||||
| 10/13/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Chronic Pain | ||||||
| 08/30/2021 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: OSTEOARTHRITIS | ||||||
| 08/25/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Opioid Analgesic | ||||||
| 07/26/2021 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $14.42 | General |
| Category: Opioid Analgesic | ||||||
| 06/16/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Neuroscience | ||||||
| 04/28/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: Opioid Analgesic | ||||||
| 03/24/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: Opioid Analgesic | ||||||
| 12/09/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | — | Food and Beverage | In-kind items and services | $17.46 | General |
| 12/08/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.54 | General |
| Category: Opioid Analgesic | ||||||
| 11/18/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/11/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: Opioid Analgesic | ||||||
| 11/09/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Neuroscience | ||||||
| 10/22/2020 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $11.42 | General |
| Category: Opioid Analgesic | ||||||
| 10/14/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Opioid Analgesic | ||||||
| 09/29/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/23/2020 | RedHill Biopharma Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Opioid Antagonist | ||||||
| 09/22/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/26/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Chronic Pain | ||||||
| 08/17/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.63 | General |
| Category: Opioid Analgesic | ||||||
| 08/10/2020 | Arbor Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Sleep | ||||||
| 08/05/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Chronic Pain | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,775 | 18,066 | $1.5M | $359,301 |
| 2022 | 13 | 2,208 | 3,973 | $618,220 | $304,865 |
| 2021 | 16 | 2,403 | 5,317 | $712,503 | $357,534 |
| 2020 | 14 | 1,703 | 3,649 | $545,543 | $276,560 |
Total Patients
9,089
Total Services
31,005
Medicare Billing
$1.3M
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 226 | 5,813 | $616,918 | $129,102 | 20.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 150 | 402 | $227,886 | $59,086 | 25.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 156 | 652 | $137,031 | $34,756 | 25.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 170 | 171 | $119,315 | $30,775 | 25.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 152 | 1,471 | $72,232 | $18,703 | 25.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 82 | 1,321 | $56,898 | $15,318 | 26.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 44 | 45 | $55,490 | $14,235 | 25.7% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2023 | 202 | 1,417 | $52,755 | $10,757 | 20.4% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2023 | 153 | 634 | $39,140 | $10,324 | 26.4% |
| J3415 | Injection, pyridoxine hcl, 100 mg | Office | 2023 | 172 | 1,024 | $31,530 | $9,803 | 31.1% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 60 | 71 | $27,564 | $7,284 | 26.4% |
| 97016 | Application of blood vessel compression device | Office | 2023 | 161 | 979 | $36,415 | $7,227 | 19.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 159 | 175 | $14,220 | $3,911 | 27.5% |
| 97032 | Application of electrical stimulation with therapist present, each 15 minutes | Office | 2023 | 60 | 291 | $12,939 | $2,741 | 21.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 19 | 19 | $4,854 | $1,292 | 26.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 95 | 96 | $4,162 | $1,161 | 27.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 163 | 231 | $3,686 | $934.91 | 25.4% |
| J3411 | Injection, thiamine hcl, 100 mg | Office | 2023 | 94 | 383 | $2,920 | $714.56 | 24.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 94 | 383 | $1,795 | $425.96 | 23.7% |
| 97750 | Test or measurement for functional capacity, each 15 minutes | Office | 2023 | 12 | 12 | $1,190 | $304.03 | 25.6% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 89 | 191 | $765.41 | $190.78 | 24.9% |
| J3480 | Injection, potassium chloride, per 2 meq | Office | 2023 | 158 | 1,890 | $936.39 | $154.58 | 16.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $282.81 | $92.40 | 32.7% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2023 | 93 | 384 | $3,202 | $7.68 | 0.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 447 | 1,604 | $186,064 | $94,156 | 50.6% |
About Dr. John Mikuzis, DO
Dr. John Mikuzis, DO is a Physical Medicine & Rehabilitation healthcare provider based in Shorewood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629048178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Mikuzis, DO has received a total of $2,883 in payments from pharmaceutical and medical device companies, with $46.70 received in 2022. These payments were reported across 162 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,881).
As a Medicare-enrolled provider, Mikuzis has provided services to 9,089 Medicare beneficiaries, totaling 31,005 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Shorewood, IL
- Active Since 01/26/2006
- Last Updated 12/14/2009
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1629048178
Products in Payments
- Morphabond ER (Drug) $548.32
- Xtampza ER (Drug) $441.21
- XTAMPZA (Drug) $310.52
- BOTOX (Biological) $192.25
- BELBUCA (Drug) $189.64
- EMGALITY (Drug) $182.12
- Aimovig (Biological) $137.86
- BUNAVAIL 2.1 mg 30-count box (Drug) $132.25
- Horizant (Drug) $82.02
- DIFICID (Drug) $73.95
- Zembrace (Drug) $70.65
- Nucynta (Drug) $70.41
- Movantik (Drug) $61.79
- BOTOX THERAPEUTIC (Biological) $51.64
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $44.42
- HYMOVIS (Device) $39.52
- XTAMPZAER (Drug) $35.20
- Gralise (Drug) $28.12
- Zembrace SymTouch Sumatriptan Injection (Drug) $21.80
- XTAMPZA ER (Drug) $18.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Shorewood
Trinh Truong, Md, MD
Physical Medicine & Rehabilitation — Payments: $9,903
Physical Medicine & Rehabilitation $9,903
Robert Yee, Md, MD
Physical Medicine & Rehabilitation — Payments: $25.56
Physical Medicine & Rehabilitation $25.56
Gary Golden, D.o, D.O
Physical Medicine & Rehabilitation
Physical Medicine & Rehabilitation